| Lower body lymphedema in patients with gynecologic cancer N Biglia, V Zanfagnin, A Daniele, E Robba, VE Bounous Anticancer Research 37 (8), 4005-4015, 2017 | 137 | 2017 |
| Risk factors, clinical presentation, and outcomes for abdominal wall endometriosis Z Khan, V Zanfagnin, SA El-Nashar, AO Famuyide, GS Daftary, ... Journal of minimally invasive gynecology 24 (3), 478-484, 2017 | 109 | 2017 |
| Prospective Validation of an Ex Vivo, Patient-Derived 3D Spheroid Model for Response Predictions in Newly Diagnosed Ovarian Cancer S Shuford, C Wilhelm, M Rayner, A Elrod, M Millard, C Mattingly, ... Scientific reports 9 (1), 11153, 2019 | 60 | 2019 |
| Prevention of human lymphoproliferative tumor formation in ovarian cancer patient-derived xenografts KA Butler, X Hou, MA Becker, V Zanfagnin, S Enderica-Gonzalez, ... Neoplasia 19 (8), 628-636, 2017 | 59 | 2017 |
| Current challenges in HER2-positive breast cancer F Puglisi, C Fontanella, V Amoroso, GV Bianchi, G Bisagni, C Falci, ... Critical Reviews in Oncology/Hematology 98, 211-221, 2016 | 59 | 2016 |
| Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers G Colon-Otero, V Zanfagnin, X Hou, NR Foster, EJ Asmus, ... ESMO open 5 (5), e000926, 2020 | 53 | 2020 |
| Ovarian cancer in elderly patients: patterns of care and treatment outcomes according to age and modified frailty index A Ferrero, L Fuso, E Tripodi, R Tana, A Daniele, V Zanfagnin, S Perotto, ... International Journal of Gynecologic Cancer 27 (9), 2017 | 43 | 2017 |
| Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts Y Liu, P Chanana, JI Davila, X Hou, V Zanfagnin, CD McGehee, ... Scientific reports 9 (1), 6314, 2019 | 41 | 2019 |
| Epigenetic modulation of collagen 1A1: therapeutic implications in fibrosis and endometriosis Y Zheng, Z Khan, V Zanfagnin, LF Correa, AA Delaney, GS Daftary Biology of reproduction 94 (4), 87, 1-10, 2016 | 41 | 2016 |
| Treatment of early cervical cancer: survival, complications and economical aspects P Zola, E Tripodi, V Zanfagnin, S Perotto, P Modaffari, F Martra, L Fuso Сибирский онкологический журнал, 5-13, 2012 | 23 | 2012 |
| Complications after the treatment of endometrial cancer: a prospective study using the French-Italian glossary E Piovano, L Fuso, CB Poma, A Ferrero, S Perotto, E Tripodi, E Volpi, ... International Journal of Gynecologic Cancer 24 (3), 2014 | 17 | 2014 |
| A search for predictive factors for hypersensitivity reactions to paclitaxel and platinum salts in chemotherapy for gynecologic pelvic neoplasms E Piovano, E Pivetta, P Modaffari, F Martra, C Baima Poma, S Perotto, ... Gynecologic and obstetric investigation 74 (1), 21-27, 2012 | 15 | 2012 |
| The role of surgery in recurrent endometrial cancer V Zanfagnin, A Ferrero, N Biglia, G Aletti, SE Gill, PB Makdisi, F Multinu, ... Expert review of anticancer therapy 16 (7), 741-750, 2016 | 14 | 2016 |
| Лечение раннего рака шейки матки: выживаемость, осложнения и экономические аспекты P Zola, E Tripodi, V Zanfagnin, S Perotto, P Modaffari, F Martra, L Fuso Сибирский онкологический журнал, 14-21, 2012 | 14 | 2012 |
| Predictors of extensive lymphatic dissemination and recurrences in node-positive endometrial cancer V Zanfagnin, Y Huang, ME Mc Gree, AL Weaver, J Casarin, F Multinu, ... Gynecologic Oncology 154 (3), 480-486, 2019 | 13 | 2019 |
| Results of a phase 2 trial of ribociclib and letrozole in patients with either relapsed estrogen receptor (ER)-positive ovarian cancers or relapsed ER-positive endometrial cancers. G Colon-Otero, SJ Weroha, V Zanfagnin, NR Foster, E Asmus, ... Journal of Clinical Oncology 37 (15_suppl), 5510-5510, 2019 | 12 | 2019 |
| Repurposing ceritinib induces DNA damage and enhances PARP inhibitor responses in high-grade serous ovarian carcinoma A Kanakkanthara, X Hou, TL Ekstrom, V Zanfagnin, AM Huehls, RL Kelly, ... Cancer research 82 (2), 307-319, 2022 | 11 | 2022 |
| KLF10 mediated epigenetic dysregulation of epithelial CD40/CD154 promotes endometriosis AA Delaney, Z Khan, Y Zheng, LF Correa, V Zanfagnin, CC Shenoy, ... Biology of Reproduction 95 (3), 62, 1-11, 2016 | 10 | 2016 |
| Minimally invasive compared with open surgery in high-risk endometrial cancer: A systematic review and meta-analysis G Dinoi, K Ghoniem, MH Murad, B Segarra-Vidal, V Zanfagnin, ... Obstetrics & Gynecology 141 (1), 59-68, 2023 | 8 | 2023 |
| Sentinel lymph nodes and precision surgery in gynecologic cancer K Ghoniem, SA Shazly, G Dinoi, V Zanfagnin, GE Glaser, A Mariani Clinical obstetrics and gynecology 63 (1), 12-23, 2020 | 8 | 2020 |
